Medroxyprogesterone Acetate Tablet
Product Images NDC 63629-8825

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 63629-8825). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Formula (Image 1)

Structure Formula (Image 1)
Chemical structure diagram of Medroxyprogesterone Acetate, showing its steroid backbone with attached functional groups including ketone and acetate esters.*
FDA Label Image

Label (Lbl636298825)

Label (Lbl636298825)
Medroxyprogesterone Acetate Tablets USP 2.5 mg oral tablet label with NDC 63629-8825-1, manufactured by Teva Pharmaceuticals USA and relabeled by Bryant Ranch Prepack. The label includes dosage strength, manufacturer and relabeler information, barcode, and mentions dispensing in a child-resistant container. Package size of 100 tablets indicated with Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.